Chronic pain and headache can alter brain morphology. Previous structural imaging studies in cluster headache used either volume- or surface-based morphometry to evaluate related morphological changes [2]. Studies often focused on comparing control subjects with patients with cluster headache that were either in the in-bout period of an attack or in the out-bout period of an attack [3]. Combining volume- and surface-based morphometry to evaluate cluster headache both during and between attacks may provide further insights into the pathophysiology of cluster headache.
To this end, the current study analysed 94 cluster headache patients (47 in-bout and 47 out-bout) and 47 age- and sex-matched healthy controls. Dr Kuan-Lin Lai (Taipei Veterans General Hospital, Taiwan) shared the results.
Age at onset and disease duration were comparable between in-bout and out-bout patients (P=0.059 and P=0.199, respectively) [1]. Total intracranial volume did not differ between groups (P=0.344). Volume-based morphometry showed a reduction of grey matter volume in multiple areas, confined to the pain matrix, in patients with cluster headache compared with healthy controls (P<0.05).
When grouping all patients with cluster headache, increased grey matter volume at bilateral putamen was observed. This was also found in in-bout patients but not out-bout patients. Similarly, surface-based morphometry showed reduced cortical thickness in anterior and middle cingulate, and bilateral insula cortices in all patients as a group and in in-bout patients, but not in out-bout patients. Additionally, the cortical thickness at the right insula negatively correlated with disease duration in patients during attacks. These findings are in line with previous studies [2,3]. Out-bout patients presented with reduced cortical thickness over bilateral insular and cingulate cortices and increased volume in bilateral putamen, suggesting that some of the morphological alterations may be a consequence of the perception of pain.
Combining structural and functional image analyses allowed researchers to show distinct morphological changes in patients with cluster headache during versus between attacks. These changes may be related to trait- and state-dependent effects.
- Lai KL, et al. Cortical morphological changes in cluster headache between bouts: voxel- and surface-based analyses. AL06, IHC 2021, 8–12 September.
- Arkink EB, et al. Cephalalgia. 2017;37(3):208–13.
- Seifert CL, et al. Headache. 2012;52(9):1362–8.
Copyright ©2021 Medicom Medical Publishers
Posted on
Previous Article
« Interictal pontine metabolism in migraine patients without aura Next Article
Functional brainstem somatotopy of the trigeminal nerve during nociception »
« Interictal pontine metabolism in migraine patients without aura Next Article
Functional brainstem somatotopy of the trigeminal nerve during nociception »
Table of Contents: IHC 2021
Featured articles
Letter from the Editor
COVID-19
Telemedicine beneficial for headache care during the pandemic
Comparison of headaches after SARS-CoV-2 vaccination
Grey matter cortical changes in patients with persistent headache after COVID-19
Increased risk of cerebral venous thrombosis in COVID-19
Patient Perception and Symptoms
Predictors of health-related quality of life in cluster headache
Dry eye disease is more prevalent in migraine
Voice change and throat swelling are cranial autonomic symptoms in primary headache
Association between physical inactivity and headache disorders
Increased suicidal attempts and risks of ideation in medication-overuse headache
Cardioembolic Comorbidities
AI-enabled ECG algorithm predicts atrial fibrillation risk in migraine
Migraine may not be a risk factor for stroke
Imaging
Functional brainstem somatotopy of the trigeminal nerve during nociception
Morphological changes in cluster headache between attacks
Interictal pontine metabolism in migraine patients without aura
Genome-Wide Association Studies
Largest genome-wide association study of migraine to date
Robust evidence that cluster headache has a genetic basis
Pharmacological Treatment
Insights in drug-drug interactions facilitate rational polypharmacy
Rimegepant confers long-term improvements in MMDs
First real-world effectiveness data of erenumab is promising
Galcanezumab effective in patients with episodic or chronic cluster headache
Central effects and affected somatosensory processing with galcanezumab in migraine
Long-term safety and tolerability of atogepant in migraine
Non-Pharmacological Treatment
Occipital nerve stimulation effective and safe in chronic cluster headache
Related Articles
July 30, 2019
Fremanezumab efficacy and safety maintained over 1 year
December 10, 2024
Nitroglycerin-induced migraine targetable by different agents
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com